모야모야병 환자에서 뇌졸중 후 발생한 정신증 1예
A Case of Poststroke Psychosis in a Patient With Moyamoya Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This paper reports a patient with Moyamoya disease who developed a psychotic disorder following a stroke. A 47-year-old female with Moyamoya disease without a psychiatric history experienced persecutory delusion and auditory hallucinations after eight months of intracranial hemorrhage in the right temporal lobe. The adult was managed with low-dose antipsychotics, risperidone. A brief Psychiatric Rating Scale was performed weekly after hospitalization, and psychotic symptoms eventually were under control after three weeks following the initiation of psychotropic medication. This case suggests that low-dose antipsychotics would be effective in patients with psychosis newly developed from a stroke secondary to Moyamoya disease.
Abstract
This paper reports a patient with Moyamoya disease who developed a psychotic disorder following a stroke. A 47-year-old female with Moyamoya disease without a psychiatric history experienced persecutory delusion and auditory hallucinations after eight months of intracranial hemorrhage in the right temporal lobe. The adult was managed with low-dose antipsychotics, risperidone. A brief Psychiatric Rating Scale was performed weekly after hospitalization, and psychotic symptoms eventually were under control after three weeks following the initiation of psychotropic medication. This case suggests that low-dose antipsychotics would be effective in patients with psychosis newly developed from a stroke secondary to Moyamoya disease.
참고문헌 (29)
- World Health Organization, "Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders", Stroke, 20, pp.1407~1431 (1989)
- Hackett ML, "Neuropsychiatric outcomes of stroke", Lancet Neurol, 13, pp.525~534 (2014)
- Chemerinski E, "The neuropsychiatry of stroke", Psychosomatics, 41, pp.5~14 (2000)
- Zhang S, "Neuropsychiatric issues after stroke : clinical significance and therapeutic implications", World J Psychiatry, 10, pp.125~138 (2020)
- Caplan LR, "Primer on cerebrovascular diseases", pp.767~774 (2017), Academic Press
- Korean Neurological Association, "Textbook of neurology", pp.693~ (2017), Panmuneducation
- Natori Y, "‘Angiographic moyamoya’its definition, classification, and therapy", Clin Neurol Neurosurg 1997;99 Suppl, 99(Suppl 2), pp.S168~S172 (1997)
- Czartoski T, "Postinfectious vasculopathy with evolution to moyamoya syndrome", J Neurol Neurosurg Psychiatry, 76, pp.256~259 (2005)
- Seol HJ, "Headache in pediatric moyamoya disease : review of 204 consecutive cases", J Neurosurg, 103(5 Suppl), pp.439~442 (2005)
- Gnanavel S, "Poststroke psychosis in an 8-year-old child with moyamoya disease", BMJ Case Rep, 2013, pp.bcr2013201771~ (2013)
- Overall JE, "The brief psychiatric rating scale", Psychol Rep, 10, pp.799~812 (1962)
- Kim CY, "Psychiatric assessment instruments" (2001), Hanampc
- Ikezaki K, "The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan", Clin Neurol Neurosurg, 99(Suppl 2), pp.S183~S186 (1997)
- Saeki N, "Hemorrhagic type moyamoya disease", Clin Neurol Neurosurg, 99(Suppl 2), pp.S196~S201 (1997)
- Iwama T, "Mechanism of intracranial rebleeding in moyamoya disease", Clin Neurol Neurosurg, 99(Suppl 2), pp.S187~S190 (1997)
- Almeida OP, "Mortality associated with incident mental health disorders after stroke", Aust N Z J Psychiatry, 41, pp.274~281 (2007)
- Stangeland H, "Poststroke psychosis : a systematic review", J Neurol Neurosurg Psychiatry, 89, pp.879~885 (2018)
- Shiber JR, "Stroke registry : hemorrhagic vs ischemic strokes", Am J Emerg Med, 28, pp.331~333 (2010)
- Gurin L, "Delusions and the right hemisphere : a review of the case for the right hemisphere as a mediator of reality-based belief", J Neuropsychiatry Clin Neurosci, 29, pp.225~235 (2017)
- Rabins PV, "Risk factors for developing atypical(schizophreniform)psychosis following stroke", J Neuropsychiatry Clin Neurosci, 3, pp.6~9 (1991)
- Richards M, "Psychiatric comorbidity in moyamoya disease and preliminary guidelines for treatment", Am J Psychiatry, 176, pp.269~274 (2019)
- Wu HH, "A rare presentation of moyamoya disease mimicking schizophrenia : a case report", Asian J Psychiatr, 65, pp.102818~ (2021)
- Al-Qazzaz NK, "Cognitive impairment and memory dysfunction after a stroke diagnosis : a poststroke memory assessment", Neuropsychiatr Dis Treat, 10, pp.1677~1691 (2014)
- Leys D, "Poststroke dementia", Lancet Neurol, 4, pp.752~759 (2005)
- Mijajlović MD, "Post-stroke dementia – a comprehensive review", BMC Med, 15, pp.11~ (2017)
- Hu GC, "Post-stroke dementia: epidemiology, mechanisms and management", Int J Gerontol, 11, pp.210~214 (2017)
- Won CW, "The validity and reliability of Korean activities of daily living (K-ADL) scale", J Korean Geriatr Soc, 6, pp.98~106 (2002)
- Won CW, "The validity and reliability of Korean instrumental activities of daily living (K-IADL) scale", J Korean Geriatr Soc, 6, pp.273~280 (2002)
- Herrmann N, "Atypical antipsychotics and risk of cerebrovascular accidents", Am J Psychiatry, 161, pp.1113~1115 (2004)